umor necrosis factor-alpha (TNF-) is a proinflammatory cytokine with a broad range of pleiotropic effects. 1 The adult human heart expresses both mRNA and receptor proteins for type I and type II TNFreceptors. 2 TNF-is also expressed de novo by cardiac myocytes after certain forms of stress 3 and plays a fundamental role in various pathophysiological conditions, including acute myocarditis, myocardial infarction, sepsisassociated cardiac dysfunction, and advanced congestive heart failure. [4] [5] [6] [7] It seems likely that different processes are responsible for the early and late cardiac effects of TNF-. 8,9 Excessive production of inducible nitric oxide synthase (iNOS) has been shown to cause the late onset of functional depression in the heart, [9] [10] [11] but the mechanisms underlying the early onset of cardiac depression remain controversial.
tile Ca 2+ transients in rat cardiac myocytes. 13 A more recent report has also demonstrated that sphingosine mediates the immediate negative inotropic effects of TNF-in adult feline cardiac myocytes. 14 As mentioned earlier, although a large number of studies have been done on the intracellular signaling mechanisms that contribute to the early cardiac effects of TNF-, the modulation of the -adrenergic responses, including the ion channel regulation, remains unclear. The purpose of this study was to test the hypothesis that TNF-rapidly antagonizes the -adrenergic responses, and to provide additional information about the intracellular mechanisms underlying the rapid anti-adrenergic action of TNF-.
In cardiac myocytes, activation of -adrenergic receptors stimulates the activity of a number of different ion currents, including those conducted by L-type Ca 2+ channels and cAMP-dependent Clchannels. Although there is a report showing TNF--induced direct inhibition of L-type Ca 2+ channels, 13 the modulation of cAMP-dependent Clchannels has never been studied. The activation mechanism of the Clchannels is well known: the response is mediated by a cAMP-dependent cascade, which leads from the agonistreceptor binding to the final phosphorylation of the channel protein. [15] [16] [17] [18] Therefore we monitored the cAMP-dependent Clchannels as a reliable parameter of -adrenergic regulation.
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TNF-Rapidly Antagonizes the -Adrenergic Responses of the Chloride Current in Guinea-Pig Ventricular Myocytes
Kenji Iino, MD; Hiroyuki Watanabe, MD; Takashi Saito, MD; Satoshi Kibira, MD; Toshihiko Iijima, MD*; Mamoru Miura, MD
The purpose of this study was to test the hypothesis that tumor necrosis factor-(TNF-) rapidly antagonizes the -adrenergic responses of the chloride current and to clarify the intracellular mechanisms responsible for the anti-adrenergic action. The whole-cell patch-clamp technique was used to monitor the anti-adrenergic effects of TNF-on the cAMP-dependent chloride current (ICl) recorded from isolated guinea-pig ventricular myocytes. Ramp pulses (±120 mV; dv/dt = ±0.4 V/s) were applied from the holding potential of -40 mV. TNF-rapidly (<15 min) inhibited the isoproterenol (Iso, 0.1 mol/L)-induced ICl in a concentration-dependent manner (30-1,000 U/ml, IC50 = 144 U/ml, n=30). The inhibitory action of TNF-was also observed when ICl had been previously stimulated by 1 mol/L forskolin (n=5). Prior exposure of myocytes to 5 g/ml pertussis toxin (PTX) hardly affected the anti-adrenergic action of TNF-(n=4). However, when ICl was induced by both 8-bromo-cAMP (100 mol/L) and isobutylmethylxanthine (0.1 mmol/L), TNF-(1,000 U/ml) failed to decrease ICl amplitude (n=5). Prior exposure of myocytes to 5 mg/ml pertussis toxin (PTX) hardly affected the anti-adrenergic action of TNF-(n=4). Furthermore, despite of the presence of nitro-L-arginine methyl ester (0.1 mmol/L), a nitric oxide synthase (NOS) inhibitor, TNF-reversed the Iso-induced increase in ICl (n=5). These results suggest that TNF-rapidly antagonizes the -adrenergic responses of ICl by reducing cAMP concentration. This anti-adrenergic action is mediated by neither the PTX-sensitive G proteins regulatory pathway nor constitutive NOS activation. 
Methods

Cell Preparation
Single ventricular cells of adult guinea-pig hearts were obtained by an enzymatic dissociation method. 19 The preparation of single cells and the technique of whole-cell recording are essentially the same as previously reported. 20 Briefly, the heart was perfused through the coronary arteries with Ca 2+ -free Tyrode's solution containing 0.04% (72.8 units/ml) collagenase (Wako Pure Chemical Industry, Osaka, Japan) for 25-30 min at 36°C. The heart was then stored in the storage solution 21 at 4°C for at least 1 h. A small piece of the ventricular tissue was dissected and agitated gently in a recording chamber (0.7 ml in volume) filled with normal Tyrode's solution. The recording chamber was perfused at 2 ml/min with normal Tyrode's solution after the cell had settled on the floor of the chamber. Experiments were carried out at 36-37°C on rod-shaped quiescent single cells that had the clear striation of sarcomeres. The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No.85-23, revised 1985).
Solutions and Drugs
The composition of normal Tyrode's solution was (in mmol/L) 136.9 NaCl; 5. Human recombinant TNF-(Research Biochemicals International, Natick, MA, USA) was dissolved in distilled water at a concentration of 19.2×10 4 U/ml as a stock solution, and was diluted to various concentrations in the external solutions just before the experiments. Isoproterenol (Iso, Wako Pure Chemical Industry) was prepared as an aqueous stock solution containing an equimolar concentration of ascorbic acid. Nifedipine (Wako Pure Chemical Industry) was prepared as a stock solution in ethanol at a final concentration of 0.03%. Forskolin (Wako Pure Chemical Industry) was prepared as a stock solution in dimethyl sulfoxide (DMSO). The final concentration of DMSO was 0.1%. Nitro-L-arginine methyl ester (L-NAME) and pertussis toxin (PTX) were obtained from Sigma Chemical Co (St Louis, MO, USA). Isobutyl-methylxanthine (IBMX) was purchased from Wako Pure Chemical Industry, and carbachol and 8-bromo-cAMP were from Calbiochem Co (La Jolla, CA, USA).
The recording chamber was coated with silicon to prevent TNF-from sticking to the chamber surfaces.
Voltage Clamp and Recording Technique
The single-pipette whole-cell recording technique was used. 22 The electrode resistance ranged from 2 to 4 M when filled with the internal solution. After the formation of the gigaohm seal, the patch of membrane was disrupted by suction of -50 to -100 mmH2O. Current and voltage signals were directly stored on the hard disc of a computer running pClamp software (version 6.0.3, Axon, USA). The Clcurrent was isolated by inhibiting all K + channel currents with Cs + -containing and/or TEA-containing internal and external solutions. The L-type Ca 2+ current was blocked by adding 1 mol/L nifedipine to all external solutions. For recording ICl, a ramp pulse (±120 mV; dV/dt = ±0.4 V/s) was employed with the holding potential of -40 mV. The negative limb of the ramp pulse was used to plot the I-V curves. ICl was determined by subtraction of the current prior to the agonist application from the agonist-induced current. The liquid junctional potential between the internal and external solutions was -6 mV. Therefore, all values of potentials given in these experiments were corrected. 
Data Analysis
Values are expressed as means ± standard error of the mean of n observations, where n represents the number of cell experiments. Statistical significance was evaluated by Student's unpaired t test where appropriate. Differences with values of p<0.05 were considered to be significant. IC50 was determined after fitting the concentrationresponse curve according to a Hill's equation:
where I is the relative ICl; X is the concentration of TNF-; and n is the Hill's coefficient.
Results
Chloride Current Stability
It is known that the effect of Iso on ICl declines with time (so-called run down), 23 and experimental conditions, such as pipette resistance or intracellular GTP concentration, are implicated in the run down. 24 We first evaluated the timedependent decline of Iso-induced ICl. When the cell was exposed to the external solution containing 0.1 mol/L Iso, enhancement of membrane currents accompanied by an inward shift of the holding current was observed ( Fig 1A) .
The I-V curve of the Iso-activated membrane currents displayed weak outward rectification and reversed at -27 mV ( Fig 1B) , which is close to the equilibrium potential for Cl -(ECl = -30 mV), indicating that the Iso-induced currents were carried by Cl -. The Iso-induced ICl measured at +78 mV was normalized to the level recorded during initial exposure to Iso and the time course of the change is shown in Fig 1C. The response to 0.1 mol/L Iso appeared immediately (~40 s) and was well maintained for more than 15 min (percent run down: 10.7 %, n=10). A more quantitative analysis found the magnitude of the Iso-induced ICl preserved up to 89.3% of the initial response after 17±2 min (n=10).
Effects of TNF-on Iso-Induced ICl
To determine whether TNF-can antagonize theadrenergic responses of ICl, TNF-(1,000 U/ml) was applied to the external solution after the effect of Iso had been observed. TNF-(1,000 U/ml) strongly inhibited ICl activated by Iso (0.1 mol/L, Fig 2A) . The time course of changes in relative current at +78 mV is shown in Fig 2B. The TNF-inhibition of the Iso-induced ICl occurred within 2-5 min ( Fig 2B) .
The TNF-sensitive current was obtained as the difference between the Iso-induced ICl recorded in the absence and presence of TNF-. The I-V curve of the TNF-sensitive current had a weak outward-rectifying property and crossed at around -27 mV ( Fig 2C) , which is also near the equilibrium potential for Cl -(-30 mV). Thus, this change could be attributable to ICl. Similar results were obtained in 11 other cells and the averaged reversal potential was -25.4±0.7 mV (n=11). Ca 2+ channel current inhibition by TNF-was reported to recover after TNF-washout, 13 but in the present experiment, ICl did not recover during washout for 3 min.
Concentration -Response Relationship for the Effects of TNF-on Iso-Induced ICl
The concentration dependence of ICl inhibition by TNFwas examined in the presence of 0.1 mol/L Iso. The magnitude of the TNF-effect was evaluated as the difference between the amplitude of ICl at +78 mV in the absence and presence of TNF-( Fig 3A) . Representative data is shown in Fig 3A. TNF-(300 U/ml) failed to inhibit ICl activated by Iso (0.1 mol/L) completely. The time course of changes in the current amplitude is given in Fig 3B. The TNF-inhibition of Iso-induced ICl reached the steady state ( Fig 3B) . In Fig 3C, the relative current is calculated as a function of TNF-concentration. Each bar represents the result obtained from 5-10 cells. TNF-decreased the amplitude of Iso-induced ICl in a concentration-dependent manner (30-1,000 U/ml, n=30). The concentration for the halfmaximal effect (IC50) was 144 U/ml.
Effects of TNF-on Forskolin-Induced ICl
To determine whether or not TNF-could interfere with the binding of Iso to -adrenergic receptors, its effects on forskolin (FK), a direct activator of adenylate cyclase, 25 was examined. Although the time course of the response to FK was slower than that to Iso, FK (1 mol/L) activated ICl markedly. TNF-(1,000 U/ml) suppressed the increase in ICl induced by FK (n=5) just as in Iso-induced ICl (Fig 4) .
Effect of PTX on the ICl Inhibition by TNF-
The GTP binding regulatory proteins (G proteins) play a pivotal role in the transduction of various biological signals. Pertussis toxin (PTX) ADP-ribosylates a subunit of Gi and Go proteins and inhibits their function. 26 Because carbachol (CCh) is known to inhibit the ICl induced by Iso via PTX-sensitive G proteins, 24, 27 we investigated an association between the inhibitory action of TNF-and PTXsensitive G proteins.
After prior incubation with PTX (5 g/ml, at 36°C, >60 min), the inhibitory effect of CCh was virtually absent. However, the effect of TNF-was still observed even in PTX-treated cells, indicating less involvement of PTX sensitive G proteins ( Fig 5) .
Effects of TNF-on ICl Induced by Increased Intracellular cAMP
The effect of TNF-on ICl induced by an increase in intracellular cAMP was analyzed with the experimental protocol shown in Fig 6A. To assess whether the inhibitory action of TNF-is mediated by reducing cAMP concentration, we performed the experiment under the condition in which intracellular cAMP concentration was clamped.
The increase in intracellular cAMP was produced by adding 8-bromo-cAMP (100 mol/L) to the internal solution, and IBMX (0.1 mmol/L) to the external solution. As shown in Fig 6A, a large outwardly rectifying current was observed soon after establishing the whole-cell condition. After replacement of the standard external solution with the low Clexternal solution, the current amplitude was reduced and the effect was clear at more positive membrane potentials ( Fig 6A) . This result indicated that the current induced by the increase in cAMP might be carried mainly by Cl -. The superfusate was then changed to the standard external solution and TNF-(1,000 U/ml) was applied; however, it failed to inhibit the ICl (Fig 6) .
Effect of TNF-on the Iso-Induced ICl in the Presence of a NOS Inhibitor
TNF-is known to activate NOS and it has been recently reported that NO antagonized the -adrenergic action in cardiac myocytes. [28] [29] [30] [31] To test the hypothesis that TNF--activated NO production diminishes -adrenergic responses, we examined the effect of pretreatment with L-NAME, a specific inhibitory compound of NOS.
L-NAME (0.1 mmol/L) was added in the external solution at least 20 min before recording the control currents. Ramp pulses (±120 mV, -0.4 V/s) were applied from -40 mV of the holding potential every 15 s. To rule out the possibility that L-NAME might inhibit ICl, we first examined the effect of the absence and presence of L-NAME (0.1 mmol/L) on ICl. As summarized in Fig 7, Iso (0.1 mol/L) enhanced ICl, regardless of the presence of L-NAME, and there was no significant difference in the response to Iso (0.1 mol/L), indicating that L-NAME did not interfere with the adrenergic action of Iso on ICl. We then assessed the effect of TNFwhile NOS was inhibited by L-NAME (0.1 mmol/L). As shown in Fig 7, TNF-significantly decreased the magnitude of Iso-induced ICl despite the presence of L-NAME.
Discussion
The function of a wide variety of cardiac ion channels can be modulated by -adrenergic stimulation, which contributes to changes in pacing and the contractile activity of the heart. In various pathological conditions, TNF-evokes hemodynamic abnormalities; however, its influence on the -adrenergic response is still unclear. In the present study, we demonstrated that TNF-rapidly antagonizes theadrenergic responses of ICl. Previous studies have implicated -adrenergic hypo-responsiveness as a mechanism of the cardiodepressant effect of TNF-. [32] [33] [34] Gulick et al have reported that 100 U/ml human recombinant TNF-inhibits the Iso (0.1 mol/L) stimulated cAMP formation by 40% in cultured neonatal rat cardiac myocytes. 32 That effect was not immediate, but required several hours to become apparent. In the present study, ICl inhibition occurred within 2-5 min after TNFexposure ( Fig 2B) . We observed that TNF-reversed the increase in ICl induced by Iso (Fig 2A) . As shown in Fig 3, the potency of TNF-for inhibiting Iso (0.1 mol/L) induced ICl, given as an IC50 value, was 144 U/ml, which was almost identical to the value reported by Gulic et al. 32 However, the time course for expression of the anti-adrenergic action in the present study was much earlier than that previously reported. The ICl inhibition occurred within 2-5 min of TNF-exposure ( Fig 2B) , which indicates that TNF-rapidly (within several minutes) exerts an antiadrenergic action in adult guinea-pig ventricular myocytes. A possible reason for the discrepancy between the previous results 32 and ours might be an age difference because the anti-adrenergic action was assessed in neonatal cardiac myocytes 32 and in adult ventricular myocytes (present study). During development, modulatory responses to catecholamines can be affected by changes in the relative expression levels of the -adrenergic signaling cascade component. 35 Enhancement of ICl can be caused by a -adrenergic receptor-mediated cAMP-dependent phosphorylation of the Clchannel. To elucidate whether the inhibitory action of TNF-was exerted by a modulation of the cAMP-dependent phosphorylation pathway, pharmacological tools such as FK, 8-bromo-cAMP and IBMX, were used. As shown in Fig 4, TNF-reversed FK-induced ICl, indicating that the inhibitory action does not involve the signaling cascade upstream from adenylate cyclase. Moreover, TNFwas unable to inhibit ICl induced by 8-bromo-cAMP and IBMX (Fig 6) . The results suggest that the inhibitory action of TNF-is not caused by the direct modulation of the Clchannel, but occurs by the inhibition of adenylate cyclase and/or reducing intracellular cAMP concentration.
The effect of -adrenergic agonists is antagonized with muscarinic agonists and it is accepted that the activation of adenylate cyclase by Gs protein is inhibited by the muscarinic receptor stimulation through PTX-sensitive Gi protein. A previous report has indicated that a 72-h exposure of cardiac myocytes to immune cell cytokines inhibits cAMP accumulation elicited by -adrenergic agonist via PTX-sensitive G proteins. 33 As shown in Figs 2 and 4 , the anti-adrenergic action of TNF-could be analogous to that of muscarinic agonists. However, prior exposure to PTX did not affect the inhibitory action of TNF-on Iso-induced ICl (Fig 5) . These results suggest that the rapid anti-adrenergic action of TNF-is not mediated via the PTX-sensitive G proteins regulatory pathway. Moreover, TNF-was unable to inhibit ICl induced by 8-bromo-cAMP and IBMX (Fig 6) . These results also suggest that the inhibitory action of TNF-is not through direct modulation of Clchannel, but occurs by the inhibition of adenylate cyclase and/or reducing intracellular cAMP concentration.
Another controversial issue has been the relative importance of NOS to the anti-adrenergic action of TNF-. TNF-is known to increase the generation of NO in a number of different tissues and cell types, including cardiac myocytes, in vivo and in vitro. 36, 37 Several reports have suggested that NO plays an essential role in muscarinic inhibition of Ca 2+ current augmented by -adrenergic stimulation in rabbit nodal cells. 27, 28, 38 Balligand et al have postulated that the activation of an endogenous NOS appears to modulate cardiac myocyte responsiveness to muscarinic cholinergic and -adrenergic receptor stimulation in cultured neonatal and adult rat cells. 38 On the other hand, it has also been reported that NOS activity in guinea-pig ventricular myocytes is not involved in muscarinic inhibition of cAMP-regulated ion channels. 39 As shown in the present study, TNF-could reverse the Iso-induced increase in ICl despite the presence of L-NAME (Fig 7) , and the inhibitory effect of TNF-was commensurate with that in the absence of L-NAME. Moreover, ventricular cells were dialyzed with a relatively high concentration of EGTA (5 mmol/L), which might limit any response involving a Ca 2+ -dependent mechanism that regulates the cNOS isozymes activity. 40 These results suggest that cNOS activation is less relevant to the ICl inhibition by TNF-.
In conclusion, the present data suggest that TNF-rapidly antagonizes the increase in ICl induced by -adrenergic stimulation, and that the anti-adrenergic action is mediated by reducing cAMP concentration, probably by inhibiting adenylate cyclase activity, but not by the PTX-sensitive G proteins regulatory pathway or cNOS activation. A further direction of this study will be to clarify how TNF-reduces cAMP concentration. In addition, the possible involvement of sphingosines in the antiadrenergic action of TNFshould be addressed.
TNF-is considered to be a double facet cytokine that has beneficial or deleterious effects during heart failure. 41 TNF-may be expected to prevent the cardiotoxicity of catecholamines or counteract the positive inotropic effects of adrenergic agonists.
